GSK
741 hedge funds and large institutions have $7.84B invested in GSK in 2022 Q3 according to their latest regulatory filings, with 132 funds opening new positions, 243 increasing their positions, 273 reducing their positions, and 273 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
24% less funds holding in top 10
Funds holding in top 10: 17 → 13 (-4)
50% less capital invested
Capital invested by funds: $15.6B → $7.84B (-$7.73B)
52% less first-time investments, than exits
New positions opened: 132 | Existing positions closed: 273
Holders
741
Holding in Top 10
13
Calls
$433M
Puts
$214M
Top Buyers
| 1 | +$173M | |
| 2 | +$123M | |
| 3 | +$106M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$78.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$77.7M |
Top Sellers
| 1 | -$376M | |
| 2 | -$175M | |
| 3 | -$141M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$124M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$102M |